Menno Schoonheim
@Mennoke
Scientific director at MS Center Amsterdam | Neuroscientist | Associate Professor | @MAGNIMS | @IMSCOGS | @AnatNeu_Ams @MScentrum020 @AmsterdamUMC
You might like
It was a great pleasure to present at ECTRIMS in Barcelona, representing @MAGNIMS in our educational setting on clinical progression! With my friends @CarmenTur1 and @paolopreziosa #ECTRIMS2025
Full house at our OS group's workshop day, which starts with a big celebration of their almost finished Open Science Guidebook for Neuroscience 🥳🔓
Our latest work is out now in @GreenJournal. @BroedersTommy found that people with MS require more energy to switch between functional brain network configurations, but only if they have cognitive impairment. Interested? Read the rest here! neurology.org/doi/10.1212/WN… @AnatNeu_Ams
Thank you @ECTRIMS for a great conference! So proud of the many plenary lectures and posters from our @MScentrum020, great to see so much translation between our subspecialties. And: Best poster award goes to our very own Eva Krijnen! See you all next year!
Great work by Tom, as also just presented at @IMSCOGS: Cognitive PIRA in MS is real and actually common. Now published in @MSJ_Research
We are in Bern this week, for the 2024 @imscogs meeting. Proud of a fantastic meeting on cognition in MS, organized by prof. Penner, which I support in my role as current president. Keep an eye on our social media accounts and website for more upcoming events!
Excited to share our new review paper on the role of the cerebellum in #MultipleSclerosis! We explore structural damage and network disconnections in MS, shedding light on the little brain. 🧠📚 @Mennoke sciencedirect.com/science/articl…
Thank you all for coming! So happy to have such a great team in Amsterdam! @MScentrum020 @amsterdamumc
Today we celebrate that our @mennoke is the new scientific director of the @MScentrum020 🥳
Just a reminder: Join us in Bern in September for our next @IMSCOGS meeting and present your work on cognition in MS! See imscogs.com
imscogs.com
About | Imscogs
About | Imscogs
As president of @IMSCOGS I am very proud to announce we are back in September with a conference fully dedicated to cognition in MS. Today is #WorldMSDay, another reason to keep higlighting the immense impact cognitive dysfunction has on the daily life of people with MS. Join us!
As president of @IMSCOGS I am very proud to announce we are back in September with a conference fully dedicated to cognition in MS. Today is #WorldMSDay, another reason to keep higlighting the immense impact cognitive dysfunction has on the daily life of people with MS. Join us!
Today is #WorldMSDay. As IMSCOGS we aim to improve lives of people with MS with (and without) cognitive difficulties, through better diagnostics, understanding, monitoring and treatment. Join our next conference Bern in September! More information on imscogs.com
Great discussions on day 2 of @MAGNIMS Amsterdam. How do we measure progression on clinical scores and how do we predict this on MRI? @CarmenTur1 @FuchsTom @RosaCortese5 Claudio Gasperini, Ludwig Kappos @J_SastreGarriga Eva Strijbis
Our 41st meeting is about to start in flowery #Amsterdam Many thanks to organisers @Mennoke & @FBarkhof and all attendees! Let's go!! #MAGNIMS41
Starting June 1st, I am very honored to become the next Scientific Director of the MS Center Amsterdam. A fantastic opportunity, I really cannot wait! @MScentrum020 @amsterdamumc @AmsNeuroscience vumc.nl/nieuws/nieuwsd…
Glad to have shared the results on the treatment effects of cladribine tablets on data-driven patterns of GM atrophy in multiple sclerosis at #ISMRMBenelux. Thanks to @Mennoke & coauthors for your support!
Koubiyr et al. report white matter (WM) degeneration in #multiplesclerosis using a ‘fixel-based’ approach, which considers the full complexity of WM and shows higher sensitivity. @IsmailKoubiyr @Mennoke shorturl.at/fzX12
Higher degree of brain atrophy and lesion activity were predictive of new relapses or disability progression in #MultipleSclerosis. Five-years analysis of the REFLEX/REFLEXION study from @Mennoke @MScentrum020 @merckgroup ▶️ journals.sagepub.com/doi/full/10.11…
So proud of Marloes! She presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by MS. New insights on why the network becomes inefficient in some people with MS. Exciting times! #MSMilan2023 @MScentrum020
Grateful to have had the opportunity to present my work on functional brain dynamics yesterday at #ECTRIMS2023 in Milan. Special thanks to the co-authors and my supervisors @BroedersTommy and @Mennoke for their support! #MSMilan23 #MS
Comment with @AmitLampit in the @TheLancetNeuro on the impressive #CogEx trial on combining computerised #cognitive #training with aerobic exercise in primary progressive #MultipleSclerosis that yielded some #unexpected findings. thelancet.com/journals/laneu…
The 2024 @MAGNIMS @ECTRIMS fellowship is open! Please, visit our website for more information: magnims.eu/fellowships/20… Or contact members of the Steering Committee: @olgacicc @alexrovirarayos @rocca_mara @FBarkhof @Mennoke @J_SastreGarriga and others at magnims.eu
United States Trends
- 1. Pro Bowl N/A
- 2. Shedeur N/A
- 3. Highguard N/A
- 4. Senator Young N/A
- 5. 76ers N/A
- 6. Homan N/A
- 7. The Jito N/A
- 8. Tyler Huntley N/A
- 9. Kanye N/A
- 10. #FundHealthcareStopICE N/A
- 11. Bader N/A
- 12. Tyra N/A
- 13. Geoff N/A
- 14. Brandon Miller N/A
- 15. Paul Newman N/A
- 16. $UNH N/A
- 17. Everton N/A
- 18. Jalen Johnson N/A
- 19. Soucy N/A
- 20. #LMPD N/A
Something went wrong.
Something went wrong.